JTC Employer Solutions Trustee’s Medifast MED Stock Holding History

JTC Employer Solutions Trustee’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-275	Closed	-$32K	–	390
2022 Q4	$32K	Hold	275	–	–	﹤0.01%	300
2022 Q3	$30K	Hold	275	–	–	0.01%	247
2022 Q2	$50K	Hold	275	–	–	0.01%	191
2022 Q1	$47K	Hold	275	–	–	0.01%	214
2021 Q4	$58K	Hold	275	–	–	0.01%	206
2021 Q3	$53K	Buy	+275	New	+$67.6K	0.01%	213

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JTC Employer Solutions Trustee's MED Position: Q1 2023 in Review

JTC Employer Solutions Trustee sold out of Medifast (MED) in Q1 2023, closing a stake of 275 shares — an estimated $32K sold.

JTC Employer Solutions Trustee first reported a position in MED in Q3 2021 and held it in 6 quarters. The position peaked at $58K in Q4 2021. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

JTC Employer Solutions Trustee reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
JTC Employer Solutions Trustee sold 275 Medifast shares in Q1 2023, an estimated $32K.
JTC Employer Solutions Trustee first reported a position in Medifast in Q3 2021 and held it in 6 quarters.
JTC Employer Solutions Trustee's Medifast position peaked at $58K in Q4 2021.
267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2023, filed 26 Apr 2023.